Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: Current issues and controversies

American Journal of Clinical Pathology

Volumn 133, Issue 5, 2010, Pages 767-771

  Gao, Faye ^a   Carter, Gloria ^a   Tseng, George ^a   Chivukula, Mamatha ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Atypical lobular hyperplasia; Breast core needle biopsy; Ductal carcinoma in situ; Infiltrating carcinoma; Lobular carcinoma in situ

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL ARTICLE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; NEEDLE BIOPSY; PRIORITY JOURNAL; BREAST TUMOR; CELL NUCLEUS; FEMALE; HYPERPLASIA; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; MAMMARY GLAND; MINIMAL RESIDUAL DISEASE; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; SECOND CANCER;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CELL NUCLEUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MAMMARY GLANDS, HUMAN; NEOPLASM, RESIDUAL; NEOPLASMS, SECOND PRIMARY; PROGNOSIS;

EID: 77951928844     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP04ZJQTJHQYVY     Document Type: Article

References (25)

1. Cornil AV. Les tumeurs du sein. Paris, France: Libraire Germer; 1908.
2. Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast: A long-term follow-up study. Cancer. 1985;55:2698-2708.
3. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol. 1992;23:1095-1097.
4. O'Malley FP. Lobular neoplasia: morphology, biologic potential and management in core biopsies. Presented at: 98th Annual Meeting of the United States and Canadian Academy of Pathology; March 2009; Boston, MA.
5. Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003.
6. O'Malley FP, Pinder SE. Breast Pathology. New York, NY: Elsevier; 2006.
7. Sneige N, Wang J, Baker BA, et al. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol. 2002;15:1044-1050.
8. Sinn HP, Helmchen B, Aulmann S. Concepts and problems of lobular neoplasia [in German]. Pathologe. 2006;27:373-380.
9. Tavassoli FA. Pathology of the Breast. 2nd ed. Stamford, CT: Appleton & Lange; 1999.
10. Rosen PP. Lobular carcinoma in situ. In: Rosen's Breast Pathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2002:581-626.
11. Chivukula M, Haynik DM, Brufsky A, et al. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol. 2008;32:1721-1726.
12. Cole P, Mark Elwood J, Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol. 1978;108:112-120.
13. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed 2007.
14. Rosen PP, Braun DW Jr, Lyngholm B, et al. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy. Cancer. 1981;47:813-819.
15. Rosen PP, Senie R, Schottenfeld D, et al. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg. 1979;189:377-382.
16. Urban JA. Bilaterality of cancer of the breast: biopsy of the opposite breast. Cancer. 1967;20:1867-1870.
17. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol. 2001;176:1255-1259.
18. Sapino A, Frigerio A, Peterse JL, et al. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch. 2000;436:421-430.
19. Andersen JA. Lobular carcinoma in situ of the breast: an approach to rational treatment. Cancer. 1977;39:2597-2602.
20. Haagensen CD, Lane N, Bodian C. Coexisting lobular neoplasia and carcinoma of the breast. Cancer. 1983;51:1468-1482.
21. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997;6:297-301.
22. Page DL, Schuyler PA, Dupont WD, et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361:125-129.
23. Bratthauer GL, Tavassoli FA. Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch. 2004;444:340-344.
24. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer. 1996;78:1403-1416.
25. Rakha EA, El-Sayed ME, Menon S, et al. Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2008;111:121-127.